Literature DB >> 16501172

Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features.

Henia Darr1, Yoav Mayshar, Nissim Benvenisty.   

Abstract

Human embryonic stem cells (HESCs) are pluripotent cells derived from the ICM of blastocyst stage embryos. As the factors needed for their growth are largely undefined, they are propagated on feeder cells or with conditioned media from feeder cells. This is in contrast to mouse embryonic stem cells (MESCs) where addition of leukemia inhibitory factor (LIF) replaces the need for a feeder layer. Recently, the transcription factor Nanog was suggested to allow LIF and feeder-free growth of MESCs. Here, we show that NANOG overexpression in HESCs enables their propagation for multiple passages during which the cells remain pluripotent. NANOG overexpressing cells form colonies efficiently even at a very low density, an ability lost upon excision of the transgene. Cells overexpressing NANOG downregulate expression of markers specific to the ICM and acquire expression of a marker specific to the primitive ectoderm (the consecutive pluripotent population in the embryo). Examination of global transcriptional changes upon NANOG overexpression by DNA microarray analysis reveals new markers suggested to discriminate between these populations. These results are significant in the understanding of self-renewal and pluripotency pathways in HESCs, and of their use for modeling early development in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501172     DOI: 10.1242/dev.02286

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  75 in total

1.  Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells.

Authors:  Jackelyn A Alva; Grace E Lee; Erika E Escobar; April D Pyle
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

2.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 3.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

Authors:  Said Assou; Tanguy Le Carrour; Sylvie Tondeur; Susanne Ström; Audrey Gabelle; Sophie Marty; Laure Nadal; Véronique Pantesco; Thierry Réme; Jean-Philippe Hugnot; Stéphan Gasca; Outi Hovatta; Samir Hamamah; Bernard Klein; John De Vos
Journal:  Stem Cells       Date:  2007-01-04       Impact factor: 6.277

Review 5.  Genetic modification of human embryonic stem cells.

Authors:  Xiaofeng Xia; Su-Chun Zhang
Journal:  Biotechnol Genet Eng Rev       Date:  2007

6.  Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells.

Authors:  Tong Ming Liu; Ying Nan Wu; Xi Min Guo; James Hoi Po Hui; Eng Hin Lee; Bing Lim
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

7.  Reprogramming somatic cells to their embryonic state.

Authors:  Valerie Horsley; Elaine Fuchs
Journal:  HFSP J       Date:  2007-07-27

8.  Regulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cells.

Authors:  Brian Boer; Jesse L Cox; David Claassen; Sunil Kumar Mallanna; Michelle Desler; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

Review 9.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

10.  Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.

Authors:  Mari Ohnuki; Koji Tanabe; Kenta Sutou; Ito Teramoto; Yuka Sawamura; Megumi Narita; Michiko Nakamura; Yumie Tokunaga; Masahiro Nakamura; Akira Watanabe; Shinya Yamanaka; Kazutoshi Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.